Diabetic Peripheral Neuropathic Pain
5 competing products in clinical development for Diabetic Peripheral Neuropathic Pain.
Pipeline by Phase
Phase 21
Phase 33
Approved1
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Duloxetine + Pregabalin + Placebo | Shionogi | Approved | Completed | 43 |
| DS-5565 + placebo | Daiichi Sankyo | Phase 3 | Completed | 40 |
| Mirogabalin + Placebo | Daiichi Sankyo | Phase 3 | Completed | 40 |
| DS-5565 | Daiichi Sankyo | Phase 3 | Completed | 40 |
| LY3857210 + Placebo | Eli Lilly | Phase 2 | Completed | 35 |